- Home
- GLSI vs TPIC Comparison
GLSI vs TPIC Comparison
Compare GLSI & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- TPIC
- Stock Information
- Founded
- GLSI 2006
- TPIC 1968
- Country
- GLSI United States
- TPIC United States
- Employees
- GLSI N/A
- TPIC N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- TPIC Industrial Machinery/Components
- Sector
- GLSI Health Care
- TPIC Industrials
- Exchange
- GLSI Nasdaq
- TPIC Nasdaq
- Market Cap
- GLSI 197.1M
- TPIC 57.1M
- IPO Year
- GLSI 2020
- TPIC 2016
- Fundamental
- Price
- GLSI $12.28
- TPIC $1.21
- Analyst Decision
- GLSI Strong Buy
- TPIC Hold
- Analyst Count
- GLSI 1
- TPIC 5
- Target Price
- GLSI $38.00
- TPIC $3.36
- AVG Volume (30 Days)
- GLSI 28.8K
- TPIC 1.2M
- Earning Date
- GLSI 11-14-2024
- TPIC 11-07-2024
- Dividend Yield
- GLSI N/A
- TPIC N/A
- EPS Growth
- GLSI N/A
- TPIC N/A
- EPS
- GLSI N/A
- TPIC N/A
- Revenue
- GLSI N/A
- TPIC $1,301,740,000.00
- Revenue This Year
- GLSI N/A
- TPIC N/A
- Revenue Next Year
- GLSI N/A
- TPIC $16.79
- P/E Ratio
- GLSI N/A
- TPIC N/A
- Revenue Growth
- GLSI N/A
- TPIC N/A
- 52 Week Low
- GLSI $8.00
- TPIC $1.15
- 52 Week High
- GLSI $21.44
- TPIC $5.75
- Technical
- Relative Strength Index (RSI)
- GLSI 37.31
- TPIC 26.09
- Support Level
- GLSI $13.11
- TPIC $1.21
- Resistance Level
- GLSI $13.73
- TPIC $1.42
- Average True Range (ATR)
- GLSI 0.77
- TPIC 0.18
- MACD
- GLSI -0.13
- TPIC 0.01
- Stochastic Oscillator
- GLSI 2.45
- TPIC 5.77
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. Its Product Candidates include; GP2, a HER2/neu transmembrane peptide that elicits a targeted immune response against HER2/neu-expressing cancers, GM-CSF Immunoadjuvant has been shown to enhance monocyte and neutrophil cytotoxicity against melanoma tumor cells and to enhance activity-dependent cellular cytotoxicity of monocytes and neutrophils against targets coated with the anti-ganglioside antibodies, and Cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells to inhibit the spread of cancer.
About TPIC TPI Composites Inc.
TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.